For the first time, our study evaluated the potential of evaluating leptin and sICAM-1 for clinical diagnosis and determined the cutoff values of these targets for the differential diagnosis of sarcoidosis and tuberculosis. This evidence concerns the gene LEP and sarcoidosis.